Squamous cell lung carcinoma
Information
- Disease name
- Squamous cell lung carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02186847 | Active, not recruiting | Phase 2 | Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer | August 2014 | April 16, 2025 |
| NCT01294306 | Completed | Phase 2 | MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy | February 2011 | August 2015 |
| NCT01737502 | Completed | Phase 1/Phase 2 | Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer | May 14, 2014 | April 24, 2023 |
| NCT02920476 | Completed | Phase 2 | TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003) | July 19, 2017 | August 14, 2021 |
| NCT03199651 | Recruiting | N/A | Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer | July 17, 2017 | December 31, 2027 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030359